These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28608139)

  • 1. Doxorubicin Hydrochloride Loaded Zymosan-Polyethylenimine Biopolymeric Nanoparticles for Dual 'Chemoimmunotherapeutic' Intervention in Breast Cancer.
    Pawar VK; Singh Y; Sharma K; Shrivastav A; Sharma A; Singh A; Meher JG; Singh P; Raval K; Bora HK; Datta D; Lal J; Chourasia MK
    Pharm Res; 2017 Sep; 34(9):1857-1871. PubMed ID: 28608139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin.
    Pawar VK; Singh Y; Sharma K; Shrivastav A; Sharma A; Singh A; Meher JG; Singh P; Raval K; Kumar A; Bora HK; Datta D; Lal J; Chourasia MK
    Int J Biol Macromol; 2019 Feb; 122():1100-1114. PubMed ID: 30219515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-assemblies of J-aggregates based on a NIR dye as a multifunctional drug carrier for combination cancer therapy.
    Song X; Zhang R; Liang C; Chen Q; Gong H; Liu Z
    Biomaterials; 2015 Jul; 57():84-92. PubMed ID: 25913253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
    Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC
    Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
    Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.
    Dong DW; Tong SW; Qi XR
    J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
    Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
    J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanodiamonds-mediated doxorubicin nuclear delivery to inhibit lung metastasis of breast cancer.
    Xiao J; Duan X; Yin Q; Zhang Z; Yu H; Li Y
    Biomaterials; 2013 Dec; 34(37):9648-56. PubMed ID: 24016858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells.
    Zayed GM; Kamal I; Abdelhafez WA; M Alsharif F; Amin MA; Shaykoon MSA; Sarhan HA; Abdelsalam AM
    Pharm Res; 2018 Mar; 35(6):112. PubMed ID: 29603025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time imaging tracking of a dual-fluorescent drug delivery system based on doxorubicin-loaded globin- polyethylenimine nanoparticles for visible tumor therapy.
    Zhang Y; Wei C; Lv F; Liu T
    Colloids Surf B Biointerfaces; 2018 Oct; 170():163-171. PubMed ID: 29906701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducible polyamidoamine-magnetic iron oxide self-assembled nanoparticles for doxorubicin delivery.
    Chen J; Shi M; Liu P; Ko A; Zhong W; Liao W; Xing MM
    Biomaterials; 2014 Jan; 35(4):1240-8. PubMed ID: 24239110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bio-distribution and anti-tumor efficacy of PEG/PLA nano particles loaded doxorubicin.
    Yu JJ; Lee HA; Kim JH; Kong WH; Kim Y; Cui ZY; Park KG; Kim WS; Lee HG; Seo SW
    J Drug Target; 2007 May; 15(4):279-84. PubMed ID: 17487696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
    Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
    Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.
    Wu M; Li J; Lin X; Wei Z; Zhang D; Zhao B; Liu X; Liu J
    Biomater Sci; 2018 May; 6(6):1457-1468. PubMed ID: 29770812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy.
    Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X
    Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.
    Mazzucchelli S; Bellini M; Fiandra L; Truffi M; Rizzuto MA; Sorrentino L; Longhi E; Nebuloni M; Prosperi D; Corsi F
    Oncotarget; 2017 Jan; 8(5):8383-8396. PubMed ID: 28039473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.